| Analysis | Metabolite Name | Measured Value | Units | Genotype | Treatment |
|---|---|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | 16-HETE | 0.099108583 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | 16-HETE | 0.264085357 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | 16-HETE | 0.295908046 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | 16-HETE | 0.328815348 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | 16-HETE | 0.369866596 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | 16-HETE | 0.393400585 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | 16-HETE | 0.395551776 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | 16-HETE | 0.463513562 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | 16-HETE | intensity | Wild-type | LPS | |
| Reversed phase UNSPECIFIED ION MODE | 16-HETE | intensity | Wild-type | LPS+antiPla2g5 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|